Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 19/20 | 0.48 |
| ▸ | NQO2 | P16083 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8949011 | 0.88 | ITGB3 (0.40) | ITGB3ITGA2BNQO2 | |
| Hydrochloric Acid SCHEMBL8949138 | 0.85 | CYP4F2 (0.37) | ITGB3ITGA2B | |
| SCHEMBL8949282 | 0.80 | ITGB3 (0.49) | ITGB3ITGA2B | |
| SCHEMBL8949136 | 0.79 | ITGB3 (0.54) | ITGB3ITGA2B | |
| SCHEMBL8863340 | 0.79 | ITGB3 (0.61) | ITGB3ITGA2B | |
| SCHEMBL8949209 | 0.79 | ITGB3 (0.56) | ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL8410466 | 0.78 | ITGB3 (0.60) | ITGB3ITGA2B | |
| SCHEMBL8949071 | 0.78 | ITGB3 (0.53) | ITGB3ITGA2B | |
| SCHEMBL8949309 | 0.77 | ITGB3 (0.48) | ITGB3ITGA2B | |
| SCHEMBL8949182 | 0.77 | ITGB3 (0.52) | ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5563268-A | FOR PREVENTING CELL AGGLOMERATION, TREATING THROMBOSIS, ARTERIOSCLEROSIS, BRAIN, LUNG OR CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-10-08 | — | — | US | disclosed |
| US-5418233-A | FOR INHIBITING CELL AGGREGATION | KARL THOMAE GMBH (DE) | 1995-05-23 | — | — | US | disclosed |
| EP-0537696-A1 | Heterobiaryl derivatives, medicines containing those compounds and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1993-04-21 | — | — | EP | disclosed |